1 August 2006
SMITHS Medical, part of the global engineering business Smiths Group, announced today it has launched a new range of advanced embryo replacement catheters in response to the changing needs of fertility specialists.
The Sure-Pro and Sure-Pro Ultra catheters, which will be used for in-vitro fertilisation procedures, are the result of research by Smiths Medical into the changing needs of its customers.
The new range was showcased in June at National Infertility Day - a patient awareness event in London. Patients said they liked the idea that they could see their embryos being released thanks to the Sure-Pro Ultra catheter, which is visible under ultrasound.
Smiths Medical is the global market leader in embryo transfer products consistently striving to innovate its range and offer advanced fertility solutions to its customers.
ENDS
General media enquiries
Contact our global media and communications team at:
Please note – the press team can only answer enquiries from accredited members of the press.
Related articles
Smiths Detection receives key certification for its AI-powered threat detection technology
AI-empowered technology identifies a wide range of airport threats and meets strict EU and Dutch requirements, setting an industry benchmark
Find out more
Smiths Group supports NASA’s Europa Clipper mission to explore Jupiter’s moon, Europa
Find out more
Smiths Detection awarded major service subcontract
Providing preventative and corrective maintenance for 486 hold baggage scanning systems across 41 airports in the United States
Find out more
